REGISTERED NUMBER: 11595354 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

NANOSYRINX LTD

Page

Company Information

1

Abridged Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr J R J Healey

Dr J E Dancer

Dr B Anninga

Dr A G Johnson

Dr E Moses

Ms L E Jones

Dr H J Sanganee

REGISTERED OFFICE:

Unit 23b The Venture Centre

Sir Williams Lyons Road

University Of Warwick Science Park

Coventry

West Midlands

CV4 7EZ

REGISTERED NUMBER:

11595354 (England and Wales)

BANKERS:

HSBC Bank Plc

London

FIXED ASSETS

Intangible assets

4

116,683

93,082

Tangible assets

5

257,633

320,916

374,316

413,998

CURRENT ASSETS

Debtors

205,399

72,389

Cash at bank

9,612,590

1,968,983

9,817,989

2,041,372

CREDITORS

Amounts falling due within one year

195,638

212,550

NET CURRENT ASSETS

9,622,351

1,828,822

TOTAL ASSETS LESS CURRENT LIABILITIES

9,996,667

2,242,820

CAPITAL AND RESERVES

Called up share capital

7

10

5

Share premium

16,219,417

6,634,763

Retained earnings

(6,222,760

)

(4,391,948

)

SHAREHOLDERS' FUNDS

9,996,667

2,242,820

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 December 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 September 2025 and were signed on its behalf by:

Dr J R J Healey - Director

1.	STATUTORY INFORMATION

NanoSyrinx Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

The financial statements are presented in sterling which is the functional currency of the company and is rounded to the nearest £1.

Intangible assets

Patents are being amortised ay 6.5% per annum.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Laboratory equipment

-

5 years straight line

Fixtures and fittings

-

Over 4 years

Computer equipment

-

Over 3 years

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2023 - 17 ) .

4.	INTANGIBLE FIXED ASSETS

Totals

£

COST

At 1 January 2024

100,435

Additions

30,819

At 31 December 2024

131,254

AMORTISATION

At 1 January 2024

7,353

Amortisation for year

7,218

At 31 December 2024

14,571

NET BOOK VALUE

At 31 December 2024

116,683

At 31 December 2023

93,082

5.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 January 2024

411,619

Additions

25,908

At 31 December 2024

437,527

DEPRECIATION

At 1 January 2024

90,703

Charge for year

89,191

At 31 December 2024

179,894

NET BOOK VALUE

At 31 December 2024

257,633

At 31 December 2023

320,916

6.	LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

2024

2023

£

£

Within one year

158,753

7,030

Between one and five years

-

7,030

158,753

14,060

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2024

2023

value:

£

£

2,176,300

Ordinary

0.000001p

2

2

7,713,799

Seed Ordinary

0.000001p

8

3

10

5

26,300 Ordinary shares of 0.000001p each were allotted and fully paid for cash at par during the year.

4,509,799 Seed Ordinary shares of 0.000001p each were allotted as fully paid at a premium of 215.9p per share during the year.

8.	PENSION COMMITMENTS

The company operates a defined contribution pension scheme in respect of the directors and employees. The scheme and its assets are held by independent managers. The pension charge represents contributions due from the company and amounted to £114,476 (2023 - £91,511). At the year end there was a balance outstanding amounting to £24,806 (2023 - £347).

9.	CONTROLLING PARTY

The directors do not consider there to be a single controlling or ultimate controlling party.